274 related articles for article (PubMed ID: 15990753)
1. Prospective randomized comparison of early and late results of a carbonized stent versus a high-grade stainless steel stent of identical design: the PREVENT Trial [corrected].
Sick PB; Brosteanu O; Ulrich M; Thiele H; Niebauer J; Busch I; Schuler G
Am Heart J; 2005 Apr; 149(4):681-8. PubMed ID: 15990753
[TBL] [Abstract][Full Text] [Related]
2. Comparison of early and late results of a Carbofilm-coated stent versus a pure high-grade stainless steel stent (the Carbostent-Trial).
Sick PB; Gelbrich G; Kalnins U; Erglis A; Bonan R; Aengevaeren W; Elsner D; Lauer B; Woinke M; Brosteanu O; Schuler G
Am J Cardiol; 2004 Jun; 93(11):1351-6, A5. PubMed ID: 15165913
[TBL] [Abstract][Full Text] [Related]
3. Latin American randomized trial of balloon angioplasty vs coronary stenting for small vessels (LASMAL): immediate and long-term results.
Rodriguez A; Rodríguez Alemparte M; Fernández Pereira C; Sampaolesi A; da Rocha Loures Bueno R; Vigo F; Obregón A; Palacios IF;
Am J Med; 2005 Jul; 118(7):743-51. PubMed ID: 15989908
[TBL] [Abstract][Full Text] [Related]
4. Clinical and angiographic results of percutaneous coronary revascularization using a trilayer stainless steel-tantalum-stainless steel phosphorylcholine-coated stent: the TriMaxx trial.
Abizaid A; Popma JJ; Tanajura LF; Hattori K; Solberg B; Larracas C; Feres F; Costa Jde R; Schwartz LB
Catheter Cardiovasc Interv; 2007 Dec; 70(7):914-9. PubMed ID: 18044791
[TBL] [Abstract][Full Text] [Related]
5. Randomized comparison of a titanium-nitride-oxide-coated stent with a stainless steel stent for coronary revascularization: the TiNOX trial.
Windecker S; Simon R; Lins M; Klauss V; Eberli FR; Roffi M; Pedrazzini G; Moccetti T; Wenaweser P; Togni M; Tüller D; Zbinden R; Seiler C; Mehilli J; Kastrati A; Meier B; Hess OM
Circulation; 2005 May; 111(20):2617-22. PubMed ID: 15883209
[TBL] [Abstract][Full Text] [Related]
6. Results of the Jostent coronary stent graft implantation in various clinical settings: procedural and follow-up results.
Gercken U; Lansky AJ; Buellesfeld L; Desai K; Badereldin M; Mueller R; Selbach G; Leon MB; Grube E
Catheter Cardiovasc Interv; 2002 Jul; 56(3):353-60. PubMed ID: 12112888
[TBL] [Abstract][Full Text] [Related]
7. Local delivery of nadroparin for the prevention of neointimal hyperplasia following stent implantation: results of the IMPRESS trial. A multicentre, randomized, clinical, angiographic and intravascular ultrasound study.
Meneveau N; Schiele F; Grollier G; Farah B; Lablanche JM; Khalifé K; Machecourt J; Danchin N; Wolf JE; Simpson M; Hak JB; Bassand JP
Eur Heart J; 2000 Nov; 21(21):1767-75. PubMed ID: 11052841
[TBL] [Abstract][Full Text] [Related]
8. The PARAGON stent study: a randomized trial of a new martensitic nitinol stent versus the Palmaz-Schatz stent for treatment of complex native coronary arterial lesions.
Holmes DR; Lansky A; Kuntz R; Bell MR; Buchbinder M; Fortuna R; O'Shaughnessy CD; Popma J
Am J Cardiol; 2000 Nov; 86(10):1073-9. PubMed ID: 11074202
[TBL] [Abstract][Full Text] [Related]
9. Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II).
Serruys PW; van Hout B; Bonnier H; Legrand V; Garcia E; Macaya C; Sousa E; van der Giessen W; Colombo A; Seabra-Gomes R; Kiemeneij F; Ruygrok P; Ormiston J; Emanuelsson H; Fajadet J; Haude M; Klugmann S; Morel MA
Lancet; 1998 Aug; 352(9129):673-81. PubMed ID: 9728982
[TBL] [Abstract][Full Text] [Related]
10. Comparison of stainless steel stents coated with turbostratic carbon and uncoated stents for percutaneous coronary interventions.
Haase J; Störger H; Hofmann M; Schwarz CE; Reinemer H; Schwarz F
J Invasive Cardiol; 2003 Oct; 15(10):562-5. PubMed ID: 14519887
[TBL] [Abstract][Full Text] [Related]
11. A randomized, controlled, multicenter trial to evaluate the safety and efficacy of zotarolimus- versus paclitaxel-eluting stents in de novo occlusive lesions in coronary arteries The ZoMaxx I trial.
Chevalier B; Di Mario C; Neumann FJ; Ribichini F; Urban P; Popma JJ; Fitzgerald PJ; Cutlip DE; Williams DO; Ormiston J; Grube E; Whitbourn R; Schwartz LB;
JACC Cardiovasc Interv; 2008 Oct; 1(5):524-32. PubMed ID: 19463354
[TBL] [Abstract][Full Text] [Related]
12. Carbon coating of stents has no effect on inflammatory response to primary stent deployment.
Korkmaz ME; Tayfun E; Müderrisoglu H; Yildirir A; Ozin B; Uluçam M; Turan M
Angiology; 2002; 53(5):563-8. PubMed ID: 12365864
[TBL] [Abstract][Full Text] [Related]
13. A paclitaxel-eluting stent for the prevention of coronary restenosis.
Park SJ; Shim WH; Ho DS; Raizner AE; Park SW; Hong MK; Lee CW; Choi D; Jang Y; Lam R; Weissman NJ; Mintz GS
N Engl J Med; 2003 Apr; 348(16):1537-45. PubMed ID: 12700373
[TBL] [Abstract][Full Text] [Related]
14. Increased risk of restenosis after placement of gold-coated stents: results of a randomized trial comparing gold-coated with uncoated steel stents in patients with coronary artery disease.
Kastrati A; Schömig A; Dirschinger J; Mehilli J; von Welser N; Pache J; Schühlen H; Schilling T; Schmitt C; Neumann FJ
Circulation; 2000 May; 101(21):2478-83. PubMed ID: 10831521
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal straightening effect of stents is an additional predictor for major adverse cardiac events. Austrian Wiktor Stent Study Group and European Paragon Stent Investigators.
Gyöngyösi M; Yang P; Khorsand A; Glogar D
J Am Coll Cardiol; 2000 May; 35(6):1580-9. PubMed ID: 10807464
[TBL] [Abstract][Full Text] [Related]
16. Preliminary results of the hydroxyapatite nonpolymer-based sirolimus-eluting stent for the treatment of single de novo coronary lesions a first-in-human analysis of a third-generation drug-eluting stent system.
Costa JR; Abizaid A; Costa R; Feres F; Tanajura LF; Abizaid A; Mattos LA; Staico R; Siqueira D; Sousa AG; Bonan R; Sousa JE
JACC Cardiovasc Interv; 2008 Oct; 1(5):545-51. PubMed ID: 19463357
[TBL] [Abstract][Full Text] [Related]
17. Randomized evaluation of polytetrafluoroethylene-covered stent in saphenous vein grafts: the Randomized Evaluation of polytetrafluoroethylene COVERed stent in Saphenous vein grafts (RECOVERS) Trial.
Stankovic G; Colombo A; Presbitero P; van den Branden F; Inglese L; Cernigliaro C; Niccoli L; Bartorelli AL; Rubartelli P; Reifart N; Heyndrickx GR; Saunamäki K; Morice MC; Sgura FA; Di Mario C;
Circulation; 2003 Jul; 108(1):37-42. PubMed ID: 12821546
[TBL] [Abstract][Full Text] [Related]
18. Six- and twelve-month results from first human experience using everolimus-eluting stents with bioabsorbable polymer.
Grube E; Sonoda S; Ikeno F; Honda Y; Kar S; Chan C; Gerckens U; Lansky AJ; Fitzgerald PJ
Circulation; 2004 May; 109(18):2168-71. PubMed ID: 15123533
[TBL] [Abstract][Full Text] [Related]
19. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators.
Fischman DL; Leon MB; Baim DS; Schatz RA; Savage MP; Penn I; Detre K; Veltri L; Ricci D; Nobuyoshi M
N Engl J Med; 1994 Aug; 331(8):496-501. PubMed ID: 8041414
[TBL] [Abstract][Full Text] [Related]
20. Restenosis in gold-coated renal artery stents.
Nolan BW; Schermerhorn ML; Powell RJ; Rowell E; Fillinger MF; Rzucidlo EM; Wyers MC; Whittaker D; Zwolak RM; Walsh DB; Cronenwett JL
J Vasc Surg; 2005 Jul; 42(1):40-6. PubMed ID: 16012450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
